Literature DB >> 16097057

Overexpression of S100A4 is closely associated with progression of colorectal cancer.

Yong-Gu Cho1, Chang-Jae Kim, Suk-Woo Nam, Shin-Hee Yoon, Sug-Hyung Lee, Nam-Jin Yoo, Jung-Young Lee, Won-Sang Park.   

Abstract

AIM: To investigate whether S100A4 played an important role in the development or progression of colorectal cancer.
METHODS: A total of 124 colorectal adenocarcinoma tissue specimens were analyzed by immunohistochemistry for the expression of S100A4 protein and subsequently investigated for the gene mutations in the coding region of S100A4 gene. The specimens were collected over a 3-year period in the laboratories at our large teaching hospital in Seoul, Republic of Korea.
RESULTS: Normal colonic epithelium either failed to express or showed focal weak expression of S100A4. Moderate to strong cytoplasmic expression of S100A4 was seen in 69 (55.6%) of the 124 colorectal carcinoma tissue specimens. S100A4 expression was detected in 43 (69.4%) of 62 specimens with lymph node metastasis. Statistically, overexpression of S100A4 was significantly associated with Dukes' stage and lymph node metastasis. Nuclear staining was also observed in 24 (19.4%) of 124 samples and closely associated with Dukes' stage. However, there was no significant correlation between overexpression of S100A4 and other investigated clinico-pathologic parameters, including tumor localization, tumor size, and survival period. In mutational analysis, no gene mutation was found in the analyzed genomic area of colorectal cancer.
CONCLUSION: Overexpression of S100A4 may be closely related with the aggressiveness of colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16097057      PMCID: PMC4398735          DOI: 10.3748/wjg.v11.i31.4852

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  A simple, precise and economical microdissection technique for analysis of genomic DNA from archival tissue sections.

Authors:  J Y Lee; S M Dong; S Y Kim; N J Yoo; S H Lee; W S Park
Journal:  Virchows Arch       Date:  1998-10       Impact factor: 4.064

2.  Prognostic significance of calcium-binding protein S100A4 in colorectal cancer.

Authors:  Silvia Gongoll; Gerrit Peters; Michael Mengel; Pompiliu Piso; Jürgen Klempnauer; Hans Kreipe; Reinhard von Wasielewski
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

3.  S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.

Authors:  K Bjørnland; J O Winberg; O T Odegaard; E Hovig; T Loennechen; A O Aasen; O Fodstad; G M Maelandsmo
Journal:  Cancer Res       Date:  1999-09-15       Impact factor: 12.701

4.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

5.  Absence of mutations in the kinase domain of the Met gene and frequent expression of Met and HGF/SF protein in primary gastric carcinomas.

Authors:  W S Park; R R Oh; Y S Kim; J Y Park; M S Shin; H K Lee; S H Lee; N J Yoo; J Y Lee
Journal:  APMIS       Date:  2000-03       Impact factor: 3.205

6.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

Authors:  G M Brodeur; R C Seeger; M Schwab; H E Varmus; J M Bishop
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

7.  Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer.

Authors:  Yong Gu Cho; Suk Woo Nam; Tae Yon Kim; Young Sil Kim; Chang Jae Kim; Jik Young Park; Jong Heun Lee; Hong Sug Kim; Jong Woo Lee; Cho Hyun Park; Young Hwa Song; Sug Hyung Lee; Nam Jin Yoo; Jung Young Lee; Won Sang Park
Journal:  APMIS       Date:  2003-05       Impact factor: 3.205

8.  Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1.

Authors:  B R Davies; M P Davies; F E Gibbs; R Barraclough; P S Rudland
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

9.  p53 alterations are associated with improved prognosis in distal colonic carcinomas.

Authors:  R Soong; F Grieu; P Robbins; B Dix; D Chen; R Parsons; A House; B Iacopetta
Journal:  Clin Cancer Res       Date:  1997-08       Impact factor: 12.531

10.  S100A4 (p9Ka) protein in colon carcinoma and liver metastases: association with carcinoma cells and T-lymphocytes.

Authors:  S Taylor; S Herrington; W Prime; P S Rudland; R Barraclough
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

View more
  19 in total

1.  S100A4 silencing blocks invasive ability of esophageal squamous cell carcinoma cells.

Authors:  Dong Chen; Xue-Feng Zheng; Ze-You Yang; Dong-Xiao Liu; Guo-You Zhang; Xue-Long Jiao; Hui Zhao
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  A proximal activator of transcription in epithelial-mesenchymal transition.

Authors:  Christo D Venkov; Andrew J Link; Jennifer L Jennings; David Plieth; Tsutomu Inoue; Kojiro Nagai; Carol Xu; Yoana N Dimitrova; Frank J Rauscher; Eric G Neilson
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

Review 3.  Molecular targets and pathways involved in liver metastasis of colorectal cancer.

Authors:  Ulrich H Weidle; Fabian Birzele; Achim Krüger
Journal:  Clin Exp Metastasis       Date:  2015-06-24       Impact factor: 5.150

4.  Diagnostic and prognostic value of metastasis inducer S100A4 transcripts in plasma of colon, rectal, and gastric cancer patients.

Authors:  Ulrike Stein; Susen Burock; Pia Herrmann; Ina Wendler; Markus Niederstrasser; Klaus-Dieter Wernecke; Peter M Schlag
Journal:  J Mol Diagn       Date:  2011-03       Impact factor: 5.568

5.  Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis.

Authors:  Ulrike Stein; Franziska Arlt; Janice Smith; Ulrike Sack; Pia Herrmann; Wolfgang Walther; Margit Lemm; Iduna Fichtner; Robert H Shoemaker; Peter M Schlag
Journal:  Neoplasia       Date:  2011-02       Impact factor: 5.715

6.  Expression of protein S100A4 is a predictor of recurrence in colorectal cancer.

Authors:  Jung-Myun Kwak; Hyun-Joo Lee; Seon-Hahn Kim; Han-Kyeom Kim; Young-Jae Mok; Young-Tae Park; Jong-Sang Choi; Hong-Young Moon
Journal:  World J Gastroenterol       Date:  2010-08-21       Impact factor: 5.742

7.  Accurate molecular classification of cancer using simple rules.

Authors:  Xiaosheng Wang; Osamu Gotoh
Journal:  BMC Med Genomics       Date:  2009-10-30       Impact factor: 3.063

8.  Deregulated miR-296/S100A4 axis promotes tumor invasion by inducing epithelial-mesenchymal transition in human ovarian cancer.

Authors:  Wang Yan; Jiaqi Chen; Zhaoying Chen; Huimin Chen
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

9.  Overexpression of protein S100A4 is independently associated with overall survival in stage C colonic cancer but only in cytoplasm at the advancing tumour front.

Authors:  P S S Kho; L Jankova; C L-S Fung; C Chan; C Clarke; B P C Lin; G Robertson; M Molloy; P H Chapuis; E L Bokey; O F Dent; S Clarke
Journal:  Int J Colorectal Dis       Date:  2012-05-09       Impact factor: 2.571

Review 10.  S100 protein family in human cancer.

Authors:  Hongyan Chen; Chengshan Xu; Qing'e Jin; Zhihua Liu
Journal:  Am J Cancer Res       Date:  2014-03-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.